Two globally oriented drugmakers, Pfizer and Sanofi, are making moves that some may interpret as attempts to allay the pharma industry‘s reputation for being “only in it...

Sanofi and GSK are touting their latecomer protein-based Covid-19 vaccine as a potential game changer in the fight against the Omicron variant.

Pfizer is to invest $95 million and take an equity share of 8.1% in in Valneva in order to further support development of a vaccine for Lyme disease.

Pfizer will invest $120 million at its plant in Kalamazoo, Michigan, to support US production of its Paxlovid (nirmatrelvir) oral antiviral treatment for Covid-19. The...

Pfizer is set to start divesting its 32% stake in Haleon, the consumer health joint venture with GSK, when the British pharma completes the company’s spinoff and Haleon...

Somewhat later than expected, the US may soon be able to offer Covid-19 vaccinations for children five years of age and younger, something parents have repeatedly...

Major drugmaker Pfizer has agreed to buy US biotech Biohaven Pharmaceutical for around $11.6 billion. Founded in 2013 and based in New Haven, Connecticut, Biohaven...

Pfizer has agreed to buy privately held, clinical-stage biopharma ReViral for up to $525 million, including upfront and development milestones. ReViral is focused on...